BUFFALO, N.Y. -- Men with Type 2 diabetes who have low testosterone levels can benefit significantly from testosterone treatment.
That is the conclusion of University at Buffalo researchers who conducted the first randomized, double-blind, placebo-controlled study of testosterone treatment in Type 2 diabetic men that comprehensively investigated the role of insulin resistance and inflammation, before and after treatment with testosterone.
The study, funded by the National Institutes of Health, was published online before print in Diabetes Care in November.